FGF21 and morbid obesity: This finding implies that the patients with morbid obesity had reversed from an FGF21-resistant state 6 months after LSG, and potentially, the FGF21 level might serve as an early predictor for recovery from morbid obesity, T2DM, and metabolic diseases.